Drug Profile
BMP 2 gene therapy
Alternative Names: AAV-BMP2Latest Information Update: 24 Aug 2006
Price :
$50
*
At a glance
- Originator Washington University School of Medicine
- Class
- Mechanism of Action Osteogenesis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Bone resorption